Jan 13 (Reuters) - AbbVie ( ABBV ) has obtained the option to license a new blood cancer drug candidate from Simcere Pharmaceutical's ( SMHGF ) unit for markets outside China, in a deal valued at up to $1.06 billion, the companies said on Monday. The U.S. drugmaker will make upfront and milestone payments, and pay royalties on sales outside...

(Reuters) -The U.S. Supreme Court declined on Monday to hear a bid by Meta Platforms to avoid a multi-billion dollar class action by advertisers that accused the Facebook and Instagram parent company of overcharging them by inflating the number of people their ads might reach. The justices turned away Meta's appeal of a lower court's decision that let advertisers seek...

Lululemon Athletica Inc. ( LULU ) shares are trading higher on Monday after the company raised its fourth-quarter 2024 guidance. The athletic apparel retailer now forecasts fourth-quarter revenue of $3.56 billion – $3.58 billion versus the estimate of $3.517 billion. This reflects an 11% to 12% increase over the same period in fiscal 2023. The new guidance surpasses the company’s...

Jan 13 (Reuters) - Cleveland Cliffs ( CLF ) is partnering with peer Nucor ( NUE ) to prepare a potential bid for U.S. Steel, CNBC reported on Monday. ...